- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-26-0328537

Mahasulph (India) Private Limited
About Mahasulph (India) Private Limited
Data last updated:
Mahasulph (India) Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the chemical products or preparations of a kind used in the textiles segment of the chemicals sector. It was incorporated on 12 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24297PN2019PTC185398.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Pandurang Domale and Suraj Dilip Gawali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chimbali Gaothan Gat No. 1 At Post Chimbali Taluka Khed, Pune, Maharashtra, India – 412104.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.09 Lakh, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹1,428 (net margin 0.2%) and EBITDA of ₹1,428 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 354% over three years.
Mahasulph (India) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0328537).
Company details
Recognitions & Rankings of Mahasulph (India)
Contact details
Mahasulph (India) Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressChimbali Gaothan Gat No. 1 At Post Chimbali Taluka Khed, Pune, Maharashtra, India – 412104
- IndustryChemicals, Chemical Products Or Preparations Of A Kind Used In The Textiles, Manufacturing, Other Chemical Product
To see the full contact details of Mahasulph (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mahasulph (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mahasulph (India) Private Limited, buy the company report.
Financials of Mahasulph (India) Private Limited
FY 2025 filings availableMahasulph (India) Private Limited reported revenue of ₹6.09 Lakh (down 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 354%. EBITDA fell 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1,428 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1,428 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mahasulph (India) Private Limited, buy the company report.
Board of directors of Mahasulph (India) Private Limited
Mahasulph (India) has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Pandurang Domale | Director | 29 Jul 2022 | 4 Years 3 Months | Current |
| Suraj Dilip Gawali | Director | 18 Jan 2022 | 4 Years 9 Months | Current |
Peer comparison
Mahasulph (India) Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alstone Silicones Private Limited | ₹6.12 Lakh (FY 2024) | 0.0% | New Delhi, Delhi, India | |||
| Sreetech Pharma (India) Private Limited | ₹6.12 Lakh (FY 2023) | -43.0% | Hyderabad, Telangana, India | |||
| Curasion Remedies Private Limited | ₹6.11 Lakh (FY 2024) | -21.0% | Makaraba, Ahmedabad, Gujarat, India | |||
| Ampetic Pharma Private Limited | ₹6.1 Lakh (FY 2022) | 28.0% | Muzaffarpur, Bihar, India | |||
| Xcute Pharmaceutical Private Limited | ₹6.1 Lakh (FY 2024) | Thane, Maharashtra, India | ||||
| Mahasulph (India) Private Limitedthis company | ₹6.09 Lakh (FY 2024) | ₹1,428 | 0.2% | -3.0% | Pune, Maharashtra, India | |
| Medilexicon Pharmaceuticals Private Limited | ₹6.09 Lakh (FY 2024) | 23.0% | Jaipur, Rajasthan, India | |||
| Morsus Remedies Private Limited | ₹6.09 Lakh (FY 2018) | 538.0% | Lucknow, Uttar Pradesh, India | |||
| Nobel Enkem Private Limited | ₹6.08 Lakh (FY 2024) | 3.0% | Patna, Bihar, India | |||
| Blue E Tech Private Limited | ₹6.08 Lakh (FY 2019) | 119.0% | Chennai, Tamil Nadu, India | |||
| Jivabox (OPC) Private Limited | ₹6.08 Lakh (FY 2025) | 474.0% | Chandrapur, Maharashtra, India |
To see the full peer comparison of Mahasulph (India) Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mahasulph (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mahasulph (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mahasulph (India) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mahasulph (India) Private Limited has 8 board changes on record since 2020: 2 appointments and 6 cessations. The latest: Anil Pandurang Domale ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Mahasulph (India) is an active private limited company based in Pune, Maharashtra, India. The company works in chemical products or preparations of a kind used in the textiles, within the chemicals industry. It was incorporated on 12 July 2019 (7+ years old) and is registered under CIN U24297PN2019PTC185398.
Mahasulph (India) has 2 current directors:
- Anil Pandurang Domale - Director
- Suraj Dilip Gawali - Director
The latest financial statements of Mahasulph (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Mahasulph (India) is U24297PN2019PTC185398. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mahasulph (India) was incorporated on 12 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Mahasulph (India) by revenue are Alstone Silicones Private Limited, Sreetech Pharma (India) Private Limited, Curasion Remedies Private Limited, Ampetic Pharma Private Limited, Xcute Pharmaceutical Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anil Pandurang Domale ceased to be Additional Director on 30 Sep 2022. Suraj Dilip Gawali ceased to be Additional Director on 30 Sep 2022. Anil Pandurang Domale was appointed as Director on 29 Jul 2022. Mahasulph (India) has 8 board changes on record in total.
Yes, Mahasulph (India) is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-26-0328537).
The registered office of Mahasulph (India) is at Chimbali Gaothan Gat No. 1 At Post Chimbali Taluka Khed, Pune, Maharashtra, India – 412104.
Mahasulph (India) operates in the chemicals industry, in the chemical products or preparations of a kind used in the textiles segment.
Mahasulph (India) can be reached at its registered office: Chimbali Gaothan Gat No. 1 At Post Chimbali Taluka Khed, Pune, Maharashtra, India – 412104.

